Jeff Geschwind, MD

Consultant in Oncology

Dr. Jeff Geschwind has over 20 years of clinical and academic experience as an interventional radiologist specializing in oncology and is recognized internationally as an expert in liver cancer. He served as a principal investigator in over 40 clinical trials during his tenure at Johns Hopkins and Yale where he focused on new imaging technology, devices, drug delivery platform, combination therapy of systemic drug and loco-regional intervention, and translational studies from bench to clinic. Through his work on many investigational products, he has also accumulated a vast amount of experience interacting with the FDA.

Dr. Geschwind is a natural fit to Syntactx’s mission. He is a skilled clinician and scientist capable of understanding the world of patient care and high-level clinical research strategy and execution. With Dr. Geschwind on our team, we successfully apply our expertise in complex clinical research to clients and study sponsors focused on interventional or image-guided treatment modalities for cancer patients.

More People

Dorothy Abel

Vice President, Regulatory Strategy

Valerie Merkle, PhD

Associate Director, Regulatory Strategy

Roseann White, MA

Senior Principal Biostatistician